Back to search

Article

Immunization with E Plus NS1-2a Enhanced Protection against Dengue Virus Serotype 2 in Mice

2016-12-01

Abstract excerpt

Dengue virus (DENV), the causative agent of dengue fever (DF), is one of the most important mosquito-borne viruses that can infect humans. Although much effort has been made on prevention and control of dengue, there are currently no anti-viral drugs or worldwide approved vaccines yet. In this study, we immunized six-week-old Balb/c mice with DNA vaccine candidates E and NS1-2a of DENV serotype 2 or the combinatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
05966223-97d8-51e5-a3f1-2e9235ea8e55
DOI
10.20944/preprints201612.0006.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunization with E Plus NS1-2a Enhanced Protection against Dengue Virus Serotype 2 in MiceDOI 10.20944/preprints201612.0006.v1
Approaches of dengue control: vaccine strategies and future aspectsSemantic proximity
Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in miceSemantic proximity
T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope IdentificationSemantic proximity
Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventionsSemantic proximity
Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responsesSemantic proximity
From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.Semantic proximity
Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in MiceSemantic proximity
Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in miceSemantic proximity
Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 miceSemantic proximity
An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypesSemantic proximity
The Influence of Codon Optimization on the Immune Response and Protective Efficacy of DNA Vaccines based on the Dengue Envelope and NS1 ProteinsSemantic proximity
A Dengue VaccineSemantic proximity
Select a neighboring publication to make it the new centre.